Hirth Peter

CIK 00018137803 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001813780

Recent Transactions

20 trades

Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2026-06-25+5,860→ 5,860 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2025-06-25+5,860→ 5,860 total
Award
IO Biotech, Inc.$IOBT
Stock Option (Right to Buy)
2025-06-05+35,144→ 35,144 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-06-27+60,000→ 60,000 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-06-06+7,250→ 7,250 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2024-06-06+1,550→ 7,175 total
Award
IO Biotech, Inc.$IOBT
Stock Option (Right to Buy)
2024-06-06+45,642→ 45,642 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-28+4,411→ 4,411 total
Disposition to Issuer
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-27−15,000→ 0 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2023-07-20+20,000→ 20,000 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2023-06-13+2,500→ 5,625 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2023-06-13+15,000→ 15,000 total
Award
IO Biotech, Inc.$IOBT
Stock Option (Right to Buy)
2023-06-08+41,533→ 41,533 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2022-06-23+15,000→ 15,000 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2022-06-01+18,750→ 18,750 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2022-06-01+3,125→ 3,125 total
Award
IO Biotech, Inc.$IOBT
Stock Option (Right to Buy)
2022-05-26+23,885→ 23,885 total
Award
IO Biotech, Inc.$IOBT
Stock Option (Right to Buy)
2021-11-04+34,731→ 34,731 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2021-06-17+15,000→ 15,000 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2021-06-02−15,000→ 15,000 total

Companies

Recent Filings

Address

C/O ALIGOS THERAPEUTICS, INC. 1 CORPORATE DRIVE, 2ND FLOOR

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov